Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
11.46
-0.39 (-3.29%)
Aug 24, 2026, 4:00 PM EDT - Market closed
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $814.98 million as of August 25, 2026. Its market cap has decreased by -11.88% in one year.
Market Cap
814.98M
Enterprise Value
769.03M
1-Year Change
-11.88%
Ranking
Category
Stock Price
$11.46
ChartMarket Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $814.98M, an increase of 532.48%. That is a compound annual growth rate of 7.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 814.98M | -28.96% |
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Theravance Biopharma | 883.14M |
| Adlai Nortye | 882.25M |
| 4D Molecular Therapeutics | 874.52M |
| DBV Technologies | 862.94M |
| Obsidian Therapeutics | 862.19M |
| Rigel Pharmaceuticals | 857.22M |
| Faeth Therapeutics | 826.89M |
| Achieve Life Sciences | 822.19M |